The trial aims to evaluate the possibility of decreasing chemotherapy exposure for subjects who show an early response to ...

The trial aims to evaluate the possibility of decreasing chemotherapy exposure for subjects who show an early response to treatment ... only four cycles of nivolumab plus AVD.

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

For nearly 20 years, mesothelioma treatment options were limited to a single regimen: pemetrexed with a platinum agent. Now, ...